PHARMA SIGNALOPEN RESEARCH PLATFORM →
COMPANY RESEARCH PROFILE · UPDATED 2026-09-29

Bristol Myers Squibb

Global biopharma known for oncology and cardiovascular franchises, including Opdivo and (with Pfizer) Eliquis.

TICKERBMY
HEADQUARTERSNew Jersey, USA
STAGEApproved
ACTIVE TRIALS210

Therapeutic areas

Oncologyimmunologycardiovascular

Selected products and programs

OpdivoEliquisRevlimid

Linked curated drug profiles

nivolumab

PD-1-directed monoclonal antibody

Selected active clinical trials

A Study to Assess Efficacy and Safety of KarXT for the Treatment of Psychosis Associated With Alzheimer's Disease (ADEPT-1)

Phase 3 · Recruiting · Psychosis Associated With Alzheimer's Disease

A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder

Phase 3 · Recruiting · Bipolar-I Disorder With Mania or Mania With Mixed Features

A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-2)

Phase 3 · Recruiting · Bipolar Disorder Type I With Mania or Mania With Mixed Features

A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)

Phase 3 · Recruiting · Alzheimer Disease

A Study to Assess Efficacy and Safety of KarXT for the Treatment of Psychosis Associated With Alzheimer's Disease (ADEPT-2)

Phase 3 · Recruiting · Psychosis Associated With Alzheimer's Disease

A Study to Evaluate the Efficacy and Safety of Adjunctive KarXT for the Treatment of Mania, With or Without Mixed Features, in Participants With Bipolar-I Disorder Taking Lithium, Valproate, or Lamotrigine

Phase 3 · Recruiting · Mania

Selected patent records

US 6967208

apixaban · Expires 2026-11-21

US 7465800

lenalidomide · Expires 2027-04-27

US 6967208*PED

apixaban · Expires 2027-05-21

US 8741929

lenalidomide · Expires 2028-03-08

US 11896586

apixaban · Expires 2040-11-22

US 11896586*PED

apixaban · Expires 2041-05-22

Primary and company sources

Company and pipeline information can change. Verify material decisions against the linked primary sources.

Evidence & limits

Source: Open the source record

Record identifier
/companies/bristol-myers-squibb/
Event / action date
Not separately retained
Source update date
Not separately retained
Platform retrieval / processing date
Not separately retained

What it supports. Connections found through the catalog, identifiers, or name and alias matching, with source links where retained.

Limits. A company association is not proof of ownership or sponsorship of every linked record. Product, substance, parent-company, and subsidiary relationships may differ.

Connection basis. Catalog, identifier, or normalized name association. Product and company connections are research leads, not ownership determinations.

What this record means · Report an issue with this record